Federal Rescheduling Is Rewarding a Cannabis Supply Chain Built on Fraudulent Safety Testing
MMJ International Holdings, (MMJ), a private pharmaceutical cannabinoid development company and petitioner in the consolidated D.C. Circuit challenge to the federal marijuana rescheduling order, today called on federal regulators, courts, and Congress to scrutinize the safety and testing record of the state-licensed cannabis industry before extending it federal legitimacy under the Controlled Substances Act. The warning comes as the largest...
Read more








